HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference

February 20, 2019 at 8:00 AM EST

TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8th Annual SVB Leerink Global Healthcare Conference, being held in New York, NY on February 27March 1, 2019.

HTG Molecular Presentation Details
Thursday, February 28
3:00pm Eastern Time
Lotte New York Palace Hotel

About HTG:

HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options.


Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 535-7742

Shaun McMeans
Chief Financial Officer
HTG Molecular Diagnostics

HTG logo

Source: HTG Molecular Diagnostics, Inc.